Skip to main content

Dr Eugene O'Hare

Photo of Eugene O'Hare

Senior Lecturer



Room 0G.446, David Keir Building
School of Psychology
Queen's University Belfast
Belfast, BT7 1NN
Northern Ireland, UK


+44 (0)28 9097 4439



On obtaining Ph.D. went straight to the U.S.A. First appointment was Research Associate in Behavioural Neurophysiology at the Institute for Disabilities Studies of the University of Minnesota. From there, obtained consecutive nationally competitive Postdoctoral Fellowships from the National Institutes of Health, first in Psychoendocrinology (Department of Medicine), then in the Behavioural Neurobiology of Aging (Department of Psychiatry), and finally in Behavioural Pharmacology (Department of Pharmacology). Appointed Research Health Science Specialist at the Veterans Affairs Medical Centre Minneapolis in 1997. Returned to Northern Ireland and in 2006 became a member of staff in the School of Psychology at Queens University.

School of Psychology administrative roles

  • Advisor of Studies
  • Module Co-ordinator PSY1002 Level 1 Introductory Psychology II
  • Module Co-ordinator PSY3088 Level 3 Psychopharmacology
  • Director of Behavioural Neuropsychophysiology Laboratory
  • Member of BRU Management Committee


  • PSY1002: Introductory Psychology II (Module Co-Ordinator)
  • PSY1005: Thinking Critically About Popular Psychology
  • PSY2059: Level 2 Group Project
  • PSY2064: Perception and Psychobiology
  • PSY3001: Level 3 Thesis
  • PSY3088: Psychopharmacology (Module Co-Ordinator)


Member of the Behaviour Development and Welfare Research Cluster

Neuropsychophysiological effects of amyloid-beta in Alzheimer’s disease

The role of alpha-synuclein in Lewy body dementia

Models of congenital hypothyroidism

Opioid effects on motivation and reward.

Operant modelling of consummatory behaviours

Nanoparticle interactions in the brain


2013 Publications in International Journals

O’Hare, E., Kim, E-M., Palmer, P., Scopes, D.I.C., Spanswick, D., McMahon, B., Treherne, J.M. and Jeggo, R. (2013). Novel 5-aryloxypirmidine SEN1576 as a candidate for treatment of Alzheimer’s disease. International Journal of Neuropsychopharmacology, In Press.

O’Hare, E., Ardis T., Page, D., Scopes, D.I.C., and Kim, E-M. (2013). AbPP over-expressing transgenic rat model of Alzheimer’s disease utilizing the Tg2576 mouse protocol. Journal of Alzheimer’s Disease, 37, 77-88.

Kim, E-M., Palmer, P., Howard, V., Elsaesser, A., Taylor, A., Staats, G. and O’Hare, E. (2013). Effect of intracerebroventricular injection of Ti-O2 nanoparticles on complex behavior in the rat. Journal of Nanoscience and Nanotechnology (Special Edition), 13, 8325-8330.

O’Hare, E., Scopes, D.I.C., Kim, E-M., Palmer, P., Jones, M., Whyment, A.D., Spanswick, D., Amijee, H., Nerou, E., McMahon, B., Treherne, J.M. and Jeggo, R. (2013). Orally bioavailable small molecule drug protects memory in Alzheimer’s disease models. Neurobiology of Aging, 34, 1116-1125.

2013 International Conference Presentations

O’Hare, E. and Kim, E-M. (2013). When nanoparticles enter the brain. Korean Testing and Research Institute (KTRI) International Congress on Neurotoxicity. Kimpo, Republic of Korea.

Kim, E-M, O’Hare, E. and Reid, E. (2013). Neuropathological Characteristics of MMI-Induced Congenital Hypothyroidism and T4 Replacement. International Symposium on Biological Engineering and Natural Sciences. Bangkok, Thailand.

O’Hare, E., Elliott, J.J. and Kim, E-M. (2013). Histopathological analysis of aggregated NAC61-95 injections on astrocytic activation in rat hippocampal CA3 area at escalating time points. Eleventh International Conference on Alzheimer’s and Parkinson’s Diseases, Florence, Italy.

O’Hare, E., McMahon, B., Kim, E-M., Palmer, P., Scopes, D.I.C., Treherne, J.M., Ardah, M.T. and El-Agnaf, O.M. (2013). Memory deficits induced by intracerebroventricular injection of fibrillar a-synuclein in intact rats and alleviation following subcutaneous injection of a novel 5-aryloxypyrimidine. International Conference on Alpha-Synuclein in Parkinson’s Disease and Related Neurodegenerative Disorders. Dubai, United Arab Emirates.